
More than 5 years after the full implementation of the Affordable Care Act, outcomes data on the effects of Medicaid expansion are starting to emerge.

More than 5 years after the full implementation of the Affordable Care Act, outcomes data on the effects of Medicaid expansion are starting to emerge.

A study focusing on community pharmacies in Missouri, which has a moderate to high prevalence of COPD (6.5% to 7.5%), found that patients with COPD receiving respiratory medication from the pharmacies had high symptom burden and low medication adherence.

More than a quarter of adults aged 18 to 64 years reported they had trouble paying bills because of cancer, and over one-third reported psychological distress, according to a report from the CDC.

Two abstracts presented at the 33rd Annual Meeting of the Consortium of Multiple Sclerosis Centers analyzed biomarkers to predict progression, disease severity, and cognitive impairment in multiple sclerosis (MS).

Study findings are indicating that patients with migraine are at an increased risk of Bell palsy, and the increased risk varies among age groups.

Granting the wishes of anti-abortion groups, the Trump administration announced it will end fetal tissue research by government scientists; Insys Therapeutics has agreed to pay $225 million to settle federal investigations into allegations that the manufacturer paid kickbacks and used other illegal tactics to sell a powerful fentanyl spray; Medicaid enrollees who would potentially be subject to Medicaid work requirements are likely to face barriers to employment.

Epidemiological evidence suggests that hepatitus C infection may be a risk factor for developing Parkinson disease.

Artificial intelligence (AI) decision support systems could prevent unnecessary cardiac imaging tests for patients suffering from stable chest pain.

In a letter to CMS Administrator Seema Verma, Energy and Commerce Committee Chairman Frank Pallone Jr, D-New Jersey, and Ways and Means Committee Chairman Richard E. Neal, D-Massachusetts, have demanded information on the Trump administration’s changes to the federal marketplace, which they say can cause confusion for enrollees, weaken consumer protections, and further compromise the Affordable Care Act (ACA).

A pilot study is suggesting that ruxolitinib is safe and tolerable as maintenance therapy following allogeneic stem cell transplantation.

During the Center for Strategic & International Studies’ event “HIV/AIDS in the Unites States: The Road to 2030,” Anthony S. Fauci, MD, director of the National Institutes of Health’s National Institute of Allergy and Infectious Diseases, and Robert Redfield, MD, director, CDC, joined to explain why the country is ready and able to end the epidemic from both a policy and clinical perspective.

A recent joint American Thoracic Society and the European Respiratory Society statement urged policymakers and clinicians to take seriously the role that inhaled vapors, gas, dust, or fumes have in creating occupational respiratory disease.

The House Appropriation Committee has voted to uphold a ban on genetically modified babies; an assisted suicide bill was passed by the Maine Legislature and will head to the desk of Governor Janet Mills; Beverly Hills has become the first city in the United States to ban sales of tobacco and tobacco-related products.

Results from a new study show that most nicotine-dependent patients with chronic obstructive pulmonary disease (COPD) who attended a 3-month smoking cessation program at a single-center clinic in Japan were able to quit smoking.

Though chimeric antigen receptor (CAR) T-cell therapy has been largely touted as one of the most important advances in cancer care in recent years, the therapy comes with the risk of severe toxicities as well as increased financial burden due to the high cost of the drugs.

Outlining a set of issues that need to be addressed under the Oncology Care Model (OCM), the Community Oncology Alliance (COA) is urging the Center for Medicare & Medicaid Innovation to delay the October 2019 deadline for practices to transition to 2-sided risk under the model.

The government seeks make it easier for cancer patients to use experimental drugs; a federal judge says the FDA can regulate stem cell companies; US senators reveal a list of 400 troubled nursing homes.

Bone metastases can cause pain in patients with cancer, and 2 abstracts presented at the 2019 American Society of Clinical Oncology Annual Meeting evaluated treating this pain.

Arbaclofen extended-release tablets were found to be a safe treatment that reduced spasticity in patients with multiple sclerosis.

The essay appears as 9 states have passed laws that are designed to provoke challenges to Roe v Wade before the Supreme Court of the United States.

People living with HIV are generally at 1.5- to 2-fold higher risk for cardiovascular diseases (CVDs), including heart attacks, strokes, and heart failure, and they often face barriers to accessing care.

Contrary to conventional wisdom, higher levels of genomic instability have been associated with lower immunogenicity, which means drugs are less effective, in patients with BRCA1/2-related breast cancers, according to research published in Clinical Cancer Research.

The authors, from the CDC, say that while the decline in diabetes incidence occurred alongside public health efforts, it's too soon to assume a causal relationship.

The Illinois Senate passed an abortion rights bill; a new study presented last weekend at ASCO 2019 found the Affordable Care Act (ACA) reduced racial disparites in cancer care; Johnson & Johnson has been ordered to pay an additional $300 million in NY talcum powder case.

Evidence suggests probiotics may decrease pro-inflammatory cytokines, oxidative stress, and potentially pathogenic bacterial overgrowth in patients with Parkinson disease.

Patients with multiple sclerosis who received natalizumab therapy had lower relapse rates and reduced inflammation.

Two abstracts at the 2019 American Society of Clinical Oncology Annual Meeting analyzed bone metastases in cancer.

Long-term use of ozanimod may be associated with improved cognitive speed and higher rates of no evidence of disease activity among patients with relapsing multiple sclerosis (MS), according to 2 new abstracts presented at the 33rd Annual Meeting of the Consortium of Multiple Sclerosis Centers.

According to a recent study, people with bipolar disorder were more likely to later develop Parkinson disease (PD) compared with patients who do not have the disorder.

This is part 3 of a 3-part vaccine series covering the potential of vaccines for infectious diseases, the impact of the antivaccination movement, and the promise of vaccines for cancer treatment. Read part 1 and part 2.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
